Genetic Technologies (GENE) Fails to deliver data

Key failure to deliver metrics for Genetic Technologies:

• Last SEC data release: 2025-02-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last year FTD volume: N/A

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Genetic Technologies (GENE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Genetic Technologies (GENE) - since 2023

Genetic Technologies (GENE) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Eterna Therapeutics ERNA	S$2.02 M	S$2.16 M	🇺🇸 USA
Myriad Genetics MYGN	S$0.11 M	S$0.33 M	🇺🇸 USA
LabCorp LH	N/A	S$0.01 M	🇺🇸 USA
Quest Diagnostics DGX	S$8.42 M	S$17.21 M	🇺🇸 USA
Compugen CGEN	S$0.09 M	S$0.85 M	🇮🇱 Israel
Danaher DHR	S$13.23 M	S$0.20 B	🇺🇸 USA
Thermo Fisher Scientific TMO	S$10.99 M	S$0.16 B	🇺🇸 USA
Neogen NEOG	S$1.76 M	S$10.17 M	🇺🇸 USA